Alkeon Capital Management
ABEO icon

Alkeon Capital Management’s Abeona Therapeutics ABEO Stock Holding History

Alkeon Capital Management’s Portfolio ABEO Stock Details ABEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-2,460
Closed -$787K – 121
2018
Q3 		$787K Hold
2,460
– – ﹤0.01% 121
2018
Q2 		$984K Buy
2,460
+1,000
+68% +$437K ﹤0.01% 119
2018
Q1 		$524K Sell
1,460
-140
-9% -$52K ﹤0.01% 119
2017
Q4 		$634K Buy
+1,600
New +$662K ﹤0.01% 88

Other funds holding ABEO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
RPAM
Rhenman & Partners Asset Management Stockholm, Sweden $810M AUM 30.2% 1-Year Est. Return

Alkeon Capital Management's ABEO Position: Q4 2018 in Review

Alkeon Capital Management sold out of Abeona Therapeutics (ABEO) in Q4 2018, closing a stake of 2,460 shares — an estimated $787K sold.

Alkeon Capital Management first reported a position in ABEO in Q4 2017 and held it in 4 quarters. The position peaked at $984K in Q2 2018. 99 funds tracked by Wall St. Rank hold ABEO as of Q4 2018.

  • Alkeon Capital Management reported no remaining Abeona Therapeutics position as of Q4 2018 after selling out during the quarter.
  • Alkeon Capital Management sold 2,460 Abeona Therapeutics shares in Q4 2018, an estimated $787K.
  • Alkeon Capital Management first reported a position in Abeona Therapeutics in Q4 2017 and held it in 4 quarters.
  • Alkeon Capital Management's Abeona Therapeutics position peaked at $984K in Q2 2018.
  • 99 funds tracked by Wall St. Rank held Abeona Therapeutics as of Q4 2018.

Based on Alkeon Capital Management's 13F filing for Q4 2018, filed 14 Feb 2019.